ALLISON BROWN: Open Payments
NPI 1023729605 · FENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,148 in 199 payments from 23 companies in 2025. Trend: 2023 $1,552 · 2024 $2,567 · 2025 $3,148
Food & beverage: $3,063Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $653 |
| Arcutis Biotherapeutics, Inc. | 21 | $271 |
| Galderma Laboratories, L.P. | 18 | $254 |
| UCB, Inc. | 9 | $253 |
| PFIZER INC. | 12 | $220 |
| Organon LLC | 19 | $197 |
| E.R. Squibb & Sons, L.L.C. | 14 | $189 |
| Novartis Pharmaceuticals Corporation | 6 | $156 |
| Lilly USA, LLC | 8 | $151 |
| Janssen Biotech, Inc. | 9 | $146 |
Products named: SKYRIZI, RINVOQ, Zoryve, Bimzelx, DUPIXENT, CIBINQO, Sotyktu, TALTZ.
Industry payments across MO — which companies pay providers there.
